| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | tacrolimus | CTRPv2 | pan-cancer | AAC | 0.21 | 5e-08 |
| mRNA | pifithrin-mu | CTRPv2 | pan-cancer | AAC | 0.2 | 5e-08 |
| mRNA | triazolothiadiazine | CTRPv2 | pan-cancer | AAC | 0.17 | 5e-08 |
| mRNA | parbendazole | CTRPv2 | pan-cancer | AAC | 0.18 | 5e-08 |
| mRNA | BRD-K70511574 | CTRPv2 | pan-cancer | AAC | 0.18 | 6e-08 |
| mRNA | AZD-2281 | CTRPv2 | pan-cancer | AAC | 0.2 | 6e-08 |
| mRNA | FQI-2 | CTRPv2 | pan-cancer | AAC | 0.19 | 7e-08 |
| mRNA | Vorinostat | CTRPv2 | pan-cancer | AAC | 0.19 | 8e-08 |
| mRNA | ISOX | CTRPv2 | pan-cancer | AAC | 0.18 | 1e-07 |
| mRNA | indisulam | CTRPv2 | pan-cancer | AAC | 0.18 | 1e-07 |